- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04489901
Stria Gravidarum and Olive Oil for Pregnancy Women
The Effect of Olive Oil on Striae Gravidarum in Primiparous Women: A Randomized Controlled Clinical Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The development of striae is one of the most common skin changes in pregnancy. The aim of this study was to investigate the clinical efficacy of olive oil on the severity and progression of striae gravidarum.
This randomized controlled clinical trial included 156 primipara women who were early third trimester. They were randomly allocated into two groups: an experimental group and a control group. Women in the experimental group applied olive oil to their abdomen twice a day in the morning and evening. The control group had no intervention.Data were collected using maternal information form, Fitzpatrick Skin Type Scale and Davey's Severity Score.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Istanbul, Turkey, 34180
- Medipol University
-
Kırklareli, Turkey, 3900
- Kırklareli University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- being in the age group of 20-30 years, early third trimester (being at the 28th week of gestation), having a singleton pregnancy, being primiparous, and volunteering to participate in the study.
Exclusion Criteria:
- having a chronic disease (such as diabetes or hypertension), having striae (before 28th gestation week), having traces of scar tissue from adolescence, using cortisone cream or another kind of topical cream, having polyhydramnios, having threatened preterm labor or preterm delivery, having any disease of the skin, taking any medication regularly, having a problem preventing communication, using pharmacological or non-pharmacological methods (undergoing pharmacotherapy) to reduce nausea, and undergoing psychiatric treatment (psychotherapy).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Extra Virgin Olivei oil group
The women in the experimental (olive oil) group were asked to apply 10 cc (4 tablespoons) of extra virgin olive oil to the entire abdomen by hand without massaging twice a day in the morning and evening.
|
To apply 10 cc (4 tablespoons) of extra virgin olive oil to the entire abdomen by hand without massaging twice a day in the morning and evening.
|
No Intervention: Control group
The women in the control group did not undergo any intervention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Prevent the severity and progression of SG
Time Frame: All the participating women were followed-up from the 28th week of gestation to the 37th week of gestation.
|
The participants completed the Maternal Information Forms through face-to-face interviews with an unbiased midwife who was working in the outpatient clinic on the day the data were collected.The women in the experimental group were asked to apply 10 cc (4 tablespoons) of extra virgin olive oil to the entire abdomen by hand without massaging twice a day in the morning and evening.
The control group did not undergo any intervention.
The women were called via telephone by the researcher once a week and asked whether they were performing the application.
Women who were not applying the olive oil or who were using other medicines or creams (at least three days a week) were excluded from the study.
The women in the control group were asked whether they were performing any applications.
Those who were applying any products were also excluded.
The striae was evaluated all groups at 37 weeks of gestation based on the Fitzpatrick Skin Type Scale and Davey's Severity Score by obstetrician.
|
All the participating women were followed-up from the 28th week of gestation to the 37th week of gestation.
|
Maternal information form
Time Frame: All the participating women were followed-up from the 28th week of gestation to the 37th week of gestation.
|
The Maternal Information Form was used to select whether pregnant women met the study.This form, which was developed by the researchers in line with knowledge of the literature, included 30 items questioning the participants' sociodemographic ch criteria.
|
All the participating women were followed-up from the 28th week of gestation to the 37th week of gestation.
|
The Fitzpatrick Skin Type Scale
Time Frame: All the participating women were followed-up from the 28th week of gestation to the 37th week of gestation.
|
The Fitzpatrick Skin Type Scale was developed by Fitzpatrick in 1975 to classify skin type.This scale uses genetic structure, eye color, reaction to sunlight to assign a skin type.
According to the scale, the skin types vary from the extremely sensitive type, which always burns and does not tan, to the sun-resistant type, which is darkly pigmen and response to sunlight.
|
All the participating women were followed-up from the 28th week of gestation to the 37th week of gestation.
|
Davey's Severity Score
Time Frame: All the participating women were followed-up from the 28th week of gestation to the 37th week of gestation.
|
Davey's Severity Score is a scoring method developed by Davey in 1972 to measure the severity of SG.It divides the abdomen into four equal quadrants.
Each quadrant is rated as "0" for clean skin, "1" for moderate striae, and "2" for multiple striae.
Accordingly, the total score ranges from 0 to 8.
|
All the participating women were followed-up from the 28th week of gestation to the 37th week of gestation.
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: AYCA S KIRCA, Phd, Kırklareli University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KırklareliAS
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pregnancy Related
-
4YouandMeCambridge Cognition Ltd; Sema4; Evidation Health; Vector Institute of Artificial... and other collaboratorsCompletedPregnancy Related | Wearables | Pregnancy EarlyUnited States
-
Helen Keller InternationalEleanor Crook FoundationNot yet recruitingPregnancy Related | Supplementation | Postnatal Related
-
The University of Texas Health Science Center,...CompletedPregnancy Related | Pregnancy, High RiskUnited States
-
Peking Union Medical College HospitalPeking Union Medical CollegeUnknownPregnancy | Pregnancy Related | Infant | Pregnancy Disease | Risk FactorChina
-
Shaare Zedek Medical CenterUnknownPregnancy Related | Pregnancy, High Risk | Anesthesia
-
Ataturk UniversityNot yet recruiting
-
Medical College of WisconsinNot yet recruiting
-
University of PennsylvaniaNot yet recruiting
-
Centre for Infectious Disease Research in ZambiaWellcome Trust; Neopenda, PBCRecruiting
-
Emory UniversityNational Institute of Nursing Research (NINR)Recruiting
Clinical Trials on Olive oil
-
Harvard School of Public Health (HSPH)CompletedCardiovascular Disease
-
Spanish National Research CouncilAndalusian Health Service; Universidad Pablo de OlavideRecruitingType II Diabetes Mellitus | Diabetic PatientsSpain
-
Minia UniversityRecruitingOrthodontic Tooth MovementEgypt
-
University of LimerickCompletedCardiovascular Diseases | Obesity | DiabetesIreland
-
Université Catholique de LouvainCompleted
-
Javad NasrollahzadehShahid Beheshti University of Medical SciencesCompletedCardiovascular Risk FactorIran, Islamic Republic of
-
University of California, DavisActive, not recruitingHealthy | Overweight | Obese | Normal WeightUnited States
-
University of BarcelonaHospital Clinic of Barcelona; Institut d'Investigacions Biomèdiques August...Completed
-
Hospital General Nuestra Señora del PradoCompleted
-
Griffin HospitalCompletedType 2 DiabetesUnited States